Literature DB >> 18458870

Ceramide: a contributor to insulin resistance or an innocent bystander?

G Boden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18458870     DOI： 10.1007/s00125-008-1015-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  11 in total

1.  Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.

Authors:  Y Y Liu; T Y Han; A E Giuliano; N Hansen; M C Cabot
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

Review 2.  Intracellular signal transduction pathways activated by ceramide and its metabolites.

Authors:  Peter P Ruvolo
Journal:  Pharmacol Res       Date:  2003-05       Impact factor: 7.658

3.  Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle.

Authors:  Chunli Yu; Yan Chen; Gary W Cline; Dongyan Zhang; Haihong Zong; Yanlin Wang; Raynald Bergeron; Jason K Kim; Samuel W Cushman; Gregory J Cooney; Bronwyn Atcheson; Morris F White; Edward W Kraegen; Gerald I Shulman
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

Review 4.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 5.  Ceramides in insulin resistance and lipotoxicity.

Authors:  Scott A Summers
Journal:  Prog Lipid Res       Date:  2005-12-19       Impact factor: 16.195

6.  Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity.

Authors:  M Skovbro; M Baranowski; C Skov-Jensen; A Flint; F Dela; J Gorski; J W Helge
Journal:  Diabetologia       Date:  2008-05-06       Impact factor: 10.122

Review 7.  Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome.

Authors:  Roger H Unger
Journal:  Endocrinology       Date:  2003-09-04       Impact factor: 4.736

8.  Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha.

Authors:  Samar I Itani; Neil B Ruderman; Frank Schmieder; Guenther Boden
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

9.  Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.

Authors:  John M Adams; Thongchai Pratipanawatr; Rachele Berria; Elaine Wang; Ralph A DeFronzo; M Cameron Sullards; Lawrence J Mandarino
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

10.  Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes.

Authors:  M Straczkowski; I Kowalska; M Baranowski; A Nikolajuk; E Otziomek; P Zabielski; A Adamska; A Blachnio; J Gorski; M Gorska
Journal:  Diabetologia       Date:  2007-08-28       Impact factor: 10.122
View more
  15 in total

Review 1.  NLRP3 inflammasomes link inflammation and metabolic disease.

Authors:  Dominic De Nardo; Eicke Latz
Journal:  Trends Immunol       Date:  2011-07-04       Impact factor: 16.687

2.  Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells.

Authors:  Jamie Cantrell Stanford; Andrew J Morris; Manjula Sunkara; Gabriel J Popa; Kara L Larson; Sabire Özcan
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

3.  Bioactives of Artemisia dracunculus L. enhance insulin sensitivity by modulation of ceramide metabolism in rat skeletal muscle cells.

Authors:  Diana N Obanda; David M Ribnicky; Ilya Raskin; William T Cefalu
Journal:  Nutrition       Date:  2014-03-19       Impact factor: 4.008

4.  Acute hyperinsulinemia and reduced plasma free fatty acid levels decrease intramuscular triglyceride synthesis.

Authors:  Xiao-jun Zhang; Lijian Wang; Demidmaa Tuvdendorj; Zhanpin Wu; Noe A Rodriguez; David N Herndon; Robert R Wolfe
Journal:  Metabolism       Date:  2012-08-13       Impact factor: 8.694

Review 5.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

Review 6.  Sphingolipids: the nexus between Gaucher disease and insulin resistance.

Authors:  Maria Fuller
Journal:  Lipids Health Dis       Date:  2010-10-11       Impact factor: 3.876

7.  Relationship between Changes in Plasma Adiponectin Concentration and Insulin Sensitivity after Niacin Therapy.

Authors:  Gemma Fraterrigo; Elisa Fabbrini; Bettina Mittendorfer; Stephen O'Rahilly; Philipp E Scherer; Bruce W Patterson; Samuel Klein
Journal:  Cardiorenal Med       Date:  2012-07-18       Impact factor: 2.041

8.  The role of skeletal muscle sphingolipids in the development of insulin resistance.

Authors:  Marek Straczkowski; Irina Kowalska
Journal:  Rev Diabet Stud       Date:  2008-05-10

Review 9.  The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Sarah DeNucci; Jack R Wands
Journal:  Int J Environ Res Public Health       Date:  2009-07-23       Impact factor: 3.390

10.  Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content.

Authors:  Paul M Coen; John J Dubé; Francesca Amati; Maja Stefanovic-Racic; Robert E Ferrell; Frederico G S Toledo; Bret H Goodpaster
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.